Meros Polymers Overview

  • Founded
  • 2009

  • Status
  • Private

  • Latest Deal Type
  • Angel

  • (Cancelled)
  • Latest Deal Amount
  • $380K

  • Investors
  • 5

Meros Polymers General Information


Owner and opeartor of a company for the development of nano-micellar substance to solve the problem of drug solubility. The company is focused on the development of a polymer platform technology that can carry drugs to specific areas of the body and improve drug effectiveness.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Other Healthcare
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1500 Manulife Place, 10180
  • 101 Street
  • Edmonton, Alberta T5J 4K1
  • Canada
+1 (780) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Meros Polymers Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 20-Nov-2015 $380K Cancelled Generating Revenue
3. Grant 01-Jan-2013 00000 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2010 Completed Startup
1. Angel (individual) Completed Startup
To view Meros Polymers’s complete valuation and funding history, request access »

Meros Polymers Executive Team (2)

Name Title Board Seat Contact Info
Afsaneh Lavasanifar Ph.D Chief Scientific Officer, Co-Founder and Vice-President
You’re viewing 1 of 2 executive team members. Get the full list »

Meros Polymers Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alberta Heritage Foundation for Medical Research Endowment Fund Limited Partner 000 0000 000000 0
Canadian Institutes of Health Research Corporation 000 0000 000000 0
Innotech Alberta Corporation 000 0000 000000 0
National Research Council Canada Government 000 0000 000000 0
TEC Edmonton Accelerator/Incubator 000 0000 000000 0
To view Meros Polymers’s complete investors history, request access »